ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,842.63
1.12%
Dow Jones
43,006.59
1.14%
US Dollar vs MXN
20.4261
0.10%
Brent Oil
69.725
0.66%
Bitcoin
91,655.73
1.13%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Caribou Biosciences Inc (CRBU) Cotización

Caribou Biosciences Inc

Caribou Biosciences Inc (CRBU)

Amd Commo Exagr
1.15
0.05
(4.55%)
Cerrado 06 Marzo 3:00PM
Delayed by 15 minutes
1.15
0.00
(0.00%)
Fuera de horario: 5:11PM
Delayed by 15 minutes
Gráfico avanzado

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
1.15
Postura de Compra
1.13
Postura de Venta
1.19
Volume Operado de la Acción
1,059,846
1.08 Rango del Día 1.16
1.012 Rango de 52 semanas 7.74
Capitalización de Mercado [m]
104.136M
Precio Anterior
1.10
Precio de Apertura
1.12
Hora
2
@
1.13
Última hora de negociación
Volumen financiero
US$ 1,184,809
Precio Promedio Ponderado
1.1179
Volumen promedio (3 m)
1,371,417
Acciones en circulación
90,552,687
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.03
Beneficio por acción (BPA)
-1.13
turnover
34.48M
Beneficio neto
-102.07M

Acerca de Caribou Biosciences Inc

Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.cariboubio.com
Sede
Dover, Delaware, USA
Fundado
-
Caribou Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CRBU. The last closing price for Caribou Biosciences was US$1.10. Over the last year, Caribou Biosciences shares have traded in a share price range of US$ 1.012 to US$ 7.74.

Caribou Biosciences currently has 90,552,687 shares in issue. The market capitalisation of Caribou Biosciences is US$99.61 million. Caribou Biosciences has a price to earnings ratio (PE ratio) of -1.03.

CRBU Últimas noticias

Más noticias

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
CRBU (4.55%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
CRBU (4.55%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
CRBU (4.55%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
CRBU (4.55%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
CRBU (4.55%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
CRBU (4.55%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
CRBU (4.55%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
CRBU (4.55%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Febrero 2025
CRBU (4.55%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.1-81.251.251.01213170271.14260841CS
4-0.25-17.85714285711.41.491.01210644171.27902841CS
12-0.93-44.71153846152.082.081.01213714171.53439857CS
26-0.77-40.10416666671.922.99951.01213298461.85311734CS
52-6.32-84.60508701477.477.741.01216604272.59502561CS
156-7.84-87.20800889888.9913.191.01213667094.9348777CS
260-16.5-93.484419263517.6532.6451.01212402586.19769944CS

CRBU - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Caribou Biosciences?
El precio actual de las acciones de Caribou Biosciences es US$ 1.15
¿Cuántas acciones de Caribou Biosciences están en circulación?
Caribou Biosciences tiene 90,552,687 acciones en circulación
¿Cuál es la capitalización de mercado de Caribou Biosciences?
La capitalización de mercado de Caribou Biosciences es USD 99.61M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Caribou Biosciences?
Caribou Biosciences ha negociado en un rango de US$ 1.012 a US$ 7.74 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Caribou Biosciences?
El ratio precio/beneficio de Caribou Biosciences es -1.03
¿Cuál es el ratio de efectivo a ventas de Caribou Biosciences?
El ratio de efectivo a ventas de Caribou Biosciences es 3.05
¿Cuál es la moneda de reporte de Caribou Biosciences?
Caribou Biosciences presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Caribou Biosciences?
El último ingresos anual de Caribou Biosciences es USD 34.48M
¿Cuál es el último beneficio anual de Caribou Biosciences?
El último beneficio anual de Caribou Biosciences es USD -102.07M
¿Cuál es la dirección registrada de Caribou Biosciences?
La dirección registrada de Caribou Biosciences es 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
¿Cuál es la dirección del sitio web de Caribou Biosciences?
La dirección del sitio web de Caribou Biosciences es www.cariboubio.com
¿En qué sector industrial opera Caribou Biosciences?
Caribou Biosciences opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
GVVisionary Holdings Inc
US$ 3.6999
(186.81%)
188.04M
CMRXChimerix Inc
US$ 8.435
(70.06%)
118.56M
ARBBARB IOT Group Ltd
US$ 0.8262
(58.88%)
87.92M
CDXCChromaDex Corporation
US$ 8.5507
(52.69%)
18.71M
SOBRSOBR Safe Inc
US$ 0.6602
(41.04%)
10.67M
CUTRCutera Inc
US$ 0.1209
(-61.55%)
23.22M
XCURExicure Inc
US$ 9.92
(-30.53%)
133.38k
STBXStarBox Group Holdings Ltd
US$ 0.3481
(-29.20%)
2.7M
LBGJLi Bang International Corporation Inc
US$ 1.50
(-25.00%)
269.2k
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 4.7255
(-24.75%)
29.42M
NVDANVIDIA Corporation
US$ 117.30
(1.13%)
284.33M
GVVisionary Holdings Inc
US$ 3.6999
(186.81%)
188.04M
ADTXAditxt Inc
US$ 0.0592
(18.88%)
160.55M
INTCIntel Corporation
US$ 20.81
(-2.44%)
127.21M
CMRXChimerix Inc
US$ 8.435
(70.06%)
118.56M

CRBU Finanzas

Finanzas

CRBU Discussion

Ver más
theorysuit theorysuit 1 mes hace
What do you think of their shift to partial HLA matching?
👍️0
Monksdream Monksdream 2 meses hace
CRBU. Under $2
👍️0
Monksdream Monksdream 2 meses hace
CRBU under $2
👍️0
TrendTrade2016 TrendTrade2016 4 meses hace
CRBU READY TO BEAST
👍️0
TrendTrade2016 TrendTrade2016 4 meses hace
CRBU...NEW SCAN JUST GAVE ME THIS BIO
👍️0
Monksdream Monksdream 5 meses hace
CRBU under $3
👍️0
Monksdream Monksdream 5 meses hace
CRBU under $2
👍️0
Monksdream Monksdream 6 meses hace
CRBU under $3
👍️0
Monksdream Monksdream 7 meses hace
CRBU under $3
👍️0
jondoeuk jondoeuk 7 meses hace
Earlier this year development of the lead CAR-NK programme, CB-020, was stopped, and now they are out of CAR-NK altogether. They disclosed it in an SEC filing and outlined a 12% workforce reduction https://www.sec.gov/Archives/edgar/data/1619856/000161985624000054/crbu-20240716.htm

This should extend their cash runway by at least six months, into the second half of 2026.
👍️0
Monksdream Monksdream 7 meses hace
CRBU under $3
👍️0
Monksdream Monksdream 8 meses hace
CRBU new 52 week low
👍️0
Monksdream Monksdream 9 meses hace
CRBU new 52 week low
👍️0
NY1972 NY1972 9 meses hace
Without engaging macrophage long term, CART and other ACT will have persistence issue as regulatory lymphocytes and TAM recoup. AFMD has the best approach with ICE engaging a few B CBNK cells for start and engaging endogenous NK and M in the maintenance phase
👍️0
Diego Rivas Diego Rivas 9 meses hace
Any good news in here comming?
👍️0
jondoeuk jondoeuk 9 meses hace
Among patients with four or more matching HLA alleles, mPFS was 14.4 months, versus 2.8 months in patients with three or fewer matches. But this is based on a retrospective analysis, so they will need to prove the theory prospectively. It was better in LBCL, with mPFS not reached, versus 2.8 months. Also, some improvement in the now-selected dose, 80 million CAR-T cells.
👍️0
jondoeuk jondoeuk 9 meses hace
The BCMA-targeted space is already crowded enough and off-target toxicities, including agranulocytosis* could be a problem for its anti-CLL-1 CAR.

* CLL-1 is also highly expressed on almost all granulocytes and monocytes and on parts of myeloid progenitors in the normal bone marrow and peripheral blood.
👍️0
Monksdream Monksdream 9 meses hace
CRBU new 52 week low
👍️0
stocksrising stocksrising 9 meses hace
Yep, not a positive trend hence sub $3’s…fortunately other trials for varied indications could save company…
👍️0
jondoeuk jondoeuk 9 meses hace
It gets worse. The updated (CB-010) data shows that the ORR (including CR rate) has fallen, so has the mDOR, the six-month PFS is poor and the pivotal trial has been delayed until H2 2025 following a new HLA partial matching strategy. The latter completely alters (in a bad way) the commercial strategy for an allo CAR-T product. They now need thirteen different off-the-shelf batches to be able to cater to ~90% of patients based on an ideal HLA match.
👍️ 1
Monksdream Monksdream 9 meses hace
CRBU new 52 week low
👍️0
Monksdream Monksdream 10 meses hace
CRBU new 52 week low
👍️0
Monksdream Monksdream 10 meses hace
CRBU under $5
👍️0
stocksrising stocksrising 12 meses hace
It seemed like they were running on all positive cylinders, but must have blown a gasket at current Conference/ Fireside???
👍️0
Monksdream Monksdream 1 año hace
CRBU new 52 week low
👍️0
jondoeuk jondoeuk 2 años hace
Yes, with both drugs still in development. As for CRBU, they gave an update (plus public offering) https://finance.yahoo.com/news/caribou-biosciences-reports-positive-clinical-200100822.html https://investor.cariboubio.com/static-files/d818ed1a-aea2-41c1-84ea-bd05a4276cbb

Personally, there seem to be red flags, such as no expansion/persistence data. I know they give huge amounts of LD chemo, higher (I think) than anyone else, which could be generating responses, explaining why there is no dose response.
👍️0
trueblue trueblue 2 años hace
.
👍️0
trueblue trueblue 2 años hace
$23.00 price target! Now that is a good start!! Glad I loaded up! Jmo
👍️0
NY1972 NY1972 2 años hace
Didn't they buy TRIL? Just gambling with billions from US government.
👍️0
jondoeuk jondoeuk 2 años hace
PFE is very selective in who they fund https://finance.yahoo.com/news/caribou-biosciences-announces-25-million-120000433.html
👍️0
trueblue trueblue 2 años hace
Great day in my accounts again! Really liking my CRBU shares! Jmo holding for the long haul!!
👍️0
Monksdream Monksdream 2 años hace
CRBU now No 9 on the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
trueblue trueblue 2 años hace
Added to my existing shares today, I bought shares months ago. I like Crbu a crisper company! Looks like Pfizer does also! Jmo
👍️0
Stockexpertpro Stockexpertpro 2 años hace
CRBU Loss 108 Million Dollars Company only has preclinical and phase 1 in its pipeline company is Years away from having anything if ever did a stock offering at 5.33$ for 25 Million thats only 1 QTR Cash burn for this company Sell the News https://www.cariboubio.com/pipeline/
👍️0
TheFinalCD TheFinalCD 2 años hace
CRBU= JUST WOW

https://finviz.com/quote.ashx?t=CRBU&ty=c&ta=1&p=d
👍️0
Monksdream Monksdream 2 años hace
CRBU No 1 on the early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0

Su Consulta Reciente

NASDAQ
CRBU
Caribou Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios